Product Description
Overall, Europe’s urological device market was valued at €1.7 billion in 2021. Due to the global COVID-19 pandemic, this was a 10% decrease from the 2020 market value. However, this is expected to increase over the forecast period at a CAGR of 2.6% to reach €2.1 billion by 2028.
Currently, the top competitors within Europe’s urological device market is Coloplast and Wellspect Healthcare alongside other market leaders such as Becton Dickinson, Hollister Inc. and Boston Scientific.
Throughout this medical market research, we analyzed over 60 urological device companies in Europe and around the world and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, procedure volumes, and to create accurate forecasts.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
EUROPE UROLOGICAL DEVICE MARKET INSIGHTS
Overall, the urological device market is very well established. This limits the potential for substantial growth. Although companies continue to provide novel adaptations for their products, the general trend within most segments of the market is a relatively flat ASP. Additionally, the ASP has been limited by the lack of reimbursement in some countries and price pressures witnessed across Europe.
EUROPE UROLOGICAL DEVICE MARKET SHARE INSIGHTS
The European urological device market was controlled by Coloplast and Wellspect Healthcare.
In 2021, the leading competitor in the urological device market was Coloplast. The company held the leading position in the urinary catheter, urinary guidewire and erectile dysfunction device segments. It also played a significant role in the stone management device, nephrostomy device and urinary incontinence device segments.
MARKET SEGMENTATION SUMMARY
- Urinary Catheter Market – Further Segmented Into:
- Intermittent, Foley, male external catheters (MECs) and female external catheters (FECs).
- Urinary Incontinence Device Market – Further Segmented Into:
- UBAs and incontinence slings.
- BPH Treatment Device Market — Further Segmented Into:
- Devices used for transurethral resection of the prostate (TURP), laser BPH, UroLift® and Rez?m® procedures.
- Urological Endoscope Market — Further Segmented Into:
- Single-use, rigid and flexible cystoscopes, single-use, semi-rigid and flexible ureteroscopes, rigid resectoscopes and rigid nephroscopes.
- Low-Dose Radiation Brachy Therapy Device Market — Further Segmented Into:
- LDR seeds.
- Nephrostemy Market — Further Segmented Into:
- Percutaneous nephrostomy sets, nephrostomy balloon dilators and nephrostomy drainage tubes.
- Erectile Dysfunction Device Market — Further Segmented Into:
- Inflatable erectile dysfunction devices and malleable erectile dysfunction devices.
- Urinary Guidewire Market — Further Segmented Into:
- All guidewires to be used in urological procedures.
- Stone Management Device Market – Further Segmented Into:
- ESWL capital equipment, laser equipment, stone fragment retrieval devices, ureteral stents and access sheaths.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Region | Europe |
| Base Year | 2021 |
| Forecast | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
